Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rifapentine vs Rifampicin for Intensive Phase Pulmonary TB
NCT00814671Phase 2Completed
- Sponsor
- Johns Hopkins University
- Start
- Apr 2010
- Primary completion
- Jun 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of rifapentine in pulmonary tuberculosis (TB), sponsored by Johns Hopkins University. Started Apr 2010; status: completed.
02
Drugs
rifapentine
03
Conditions
pulmonary tuberculosis (TB)
Beyond the preview
Go deeper on NCT00814671.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00814671.